×
About 2,183 results

ALLMedicine™ Hormonal Contraception Center

Research & Reviews  701 results

The healthy female microbiome across body sites: effect of hormonal contraceptives and ...
https://doi.org/10.1093/humrep/deac094
Human Reproduction (Oxford, England); Krog MC, Hugerth LW et. al.

May 14th, 2022 - How does hormonal contraceptive use and menstrual cycle phase affect the female microbiome across different body sites? The menstrual cycle phase, but not hormonal contraceptive use, is associated with the vaginal and oral but not the gut microbio...

Pharmacists Expand Access to Reproductive heaLthcare
https://clinicaltrials.gov/ct2/show/NCT03830567

Apr 29th, 2022 - Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to imple...

Hormonal Contraception Use and Sexual Frequency across Young Women's Intimate Relations...
https://doi.org/10.1080/00224499.2022.2059649
Journal of Sex Research; Blumenstock SM, Barber JS

Apr 19th, 2022 - We examined whether hormonal contraception (HC) use predicts sexual frequency throughout and across young women's intimate relationships. From 2008-2012, the Relationships Dynamics and Social Life Study collected weekly surveys over 2.5 years, and...

Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and pr...
https://doi.org/10.1016/j.annepidem.2022.03.013
Annals of Epidemiology; Urbute A, Frederiksen K et. al.

Apr 12th, 2022 - To assess the association between higher-than-normal BMI and incidence of premenopausal ovarian and breast cancers. This prospective cohort study included 461,646 women registered in the Danish Medical Birth Registry with self-reported early adult...

Subtypes of Provoked Vestibulodynia
https://clinicaltrials.gov/ct2/show/NCT02712814

Apr 8th, 2022 - Background Provoked vestibulodynia (PVD) is the term describing a syndrome of provoked, localized allodynia of the vestibule of the vulva, not explained by another condition, and lasting more than 3 months. PVD is not a defined disease but rather ...

see more →

Guidelines  11 results

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200366
Maturitas Ramírez I, De la Viuda E et. al.

Jun 6th, 2020 - COVID-19 is associated with a systemic inflammatory response with activation of coagulation in symptomatic patients. The possibility of coagulopathies in peri- and postmenopausal women taking estrogen therapies makes it necessary to consider antit...

Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147901
MMWR. Morbidity and Mortality Weekly Report; Tepper NK, Curtis KM et. al.

Apr 10th, 2020 - "U.S. Medical Eligibility Criteria for Contraceptive Use" (U.S. MEC) 2016 provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1). The U.S. MEC is adapted f...

Fertility preservation, contraception and menopause hormone therapy in women treated fo...
https://doi.org/10.1016/j.ejca.2019.04.018
European Journal of Cancer (Oxford, England : 1990); Rousset-Jablonski C, Selle F et. al.

Jun 7th, 2019 - Rare ovarian tumours include complex borderline ovarian tumours, sex-cord tumours, germ cell tumours and rare epithelial tumours. Indications and modalities of fertility preservation (FP), infertility management, contraindications for hormonal con...

ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coe...
https://doi.org/10.1097/AOG.0000000000003073
Obstetrics and Gynecology;

Jan 27th, 2019 - Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data regarding women with underlying medical conditions or other special circumstances are limited. The U.S. Medical Eligibility ...

ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting ...
https://doi.org/10.1097/AOG.0000000000003072
Obstetrics and Gynecology;

Jan 27th, 2019 - Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data regarding women with underlying medical conditions or other special circumstances are limited. The U.S. Medical Eligibility ...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  35 results

Pharmacists Expand Access to Reproductive heaLthcare
https://clinicaltrials.gov/ct2/show/NCT03830567

Apr 29th, 2022 - Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to imple...

Subtypes of Provoked Vestibulodynia
https://clinicaltrials.gov/ct2/show/NCT02712814

Apr 8th, 2022 - Background Provoked vestibulodynia (PVD) is the term describing a syndrome of provoked, localized allodynia of the vestibule of the vulva, not explained by another condition, and lasting more than 3 months. PVD is not a defined disease but rather ...

Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)
https://clinicaltrials.gov/ct2/show/NCT01181778

Feb 4th, 2022 - Physicians counsel women participants who are candidates for hormonal contraception about available combined hormonal contraceptive methods (the combined pill, the contraceptive vaginal ring [i.e., the etonogestrel + ethinylestradiol vaginal ring]...

Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)
https://clinicaltrials.gov/ct2/show/NCT04331288

Jan 6th, 2022 - This study can be classified as a phase 1, single center, and drug-drug interaction (DDI) study. The within-subjects' experimental procedures will assess pharmacokinetic interactions between ethanol (EtOH) and PT150 (900 mg qd) in non-treatment-se...

The Effects of the Female Hormones on Cerebral Perfusion
https://clinicaltrials.gov/ct2/show/NCT03299179

Dec 1st, 2021 - Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cerebral perfusion and other brain parameters (grey...

see more →

News  121 results

COVID Vaccines Have Slight, Temporary Effects on Menstrual Cycles
https://www.medpagetoday.com/obgyn/generalobgyn/96547

Jan 6th, 2022 - Women who were immunized against COVID-19 experienced a slight, but non-significant, change in the length of their menstrual cycle compared with those who were unvaccinated, according to a retrospective cohort analysis. Patients experienced less t...

No Link Between Mother's Pill Use and CNS Tumors in Offspring
https://www.medscape.com/viewarticle/965959

Jan 4th, 2022 - In a large-scale study among Danish children, no statistically significant association was found between maternal hormonal contraception use and increased risk for central nervous system (CNS) tumors in their offspring. The study was based on popu...

J&J COVID Vaccine Pause Not an Overreaction, Officials Say
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/92068

Apr 13th, 2021 - FDA and CDC officials recommended pausing administration of the Johnson & Johnson COVID-19 vaccine "out of an abundance of caution," and mainly for the benefit of healthcare providers to diagnose, treat, and report severe adverse events, the agenc...

COVID-19 Impacts Women's Contraception Choices
https://www.medscape.com/viewarticle/942212

Dec 8th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The rate of unintended pregnancies in the United States has decreased to approximately 45%, based on data published in 2016, and "for the first ti...

Oral Contraceptives May Curb Severe Asthma Attacks in Young Women
https://www.medscape.com/viewarticle/941481

Nov 25th, 2020 - (Reuters Health) - Premenopausal women with asthma who use oral contraception that contains estrogen may be less likely to experience severe exacerbations, a new study suggests. An analysis of data from more than 80,000 women with asthma found a s...

see more →